Recent insider trading activity from Stetz Gary S., including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 21, 2026 | Hepion Pharmaceuticals, Inc. | $HEPA | Stetz Gary S. | Interim CEO | P | Common Stock, par value $0.0001 per share | 1250000 | $0.04 | 1,250,000.0000 | 11,620,317 | 9999.99% | 10.76% |
| Nov. 3, 2025 | Canton Strategic Holdings, Inc. | $CNTN | Stetz Gary S. | Director | A | Stock Option | 32500 | $0.00 | 82,500.0000 | 2,108,753 | 65.00% | 1.54% |